A validated score estimating ambulatory status following radiotherapy of elderly patients for metastatic spinal cord compression

BMC Cancer

Dirk Rades⁵  Jasmin N Evers⁵  Volker Rudat³  Amira Bajrovic⁴  Johann H Karstens¹  Steven E Schild² 

[1] Department of Radiation Oncology, Hannover Medical University, Hannover, Germany

[2] Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, USA

[3] Department of Radiation Oncology, Saad Specialist Hospital, Al-Khobar, Saudi Arabia

[4] Department of Radiation Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

[5] Department of Radiation Oncology, University of Lübeck, Ratzeburger Allee 160, D-23538 Lübeck, Germany

关键词: Score;    Prognostic factors;    Ambulatory status;    Elderly patients;    MSCC;   

Others  :  1125204
DOI  :  10.1186/1471-2407-14-589

 received in 2014-01-28, accepted in 2014-08-08,  发布年份 2014

【 摘 要 】

Background

This study was performed to develop a validated score predicting ambulatory status after radiotherapy (RT) alone for metastatic spinal cord compression (MSCC) in elderly patients.

Methods

1,129 elderly patients (≥65 years) were assigned to the test (N = 565) or validation group (N = 564). In the test group, nine pre-treatment factors (age, gender, tumor type, number of involved vertebrae, pre-RT ambulatory status, other bone metastases, visceral metastases, interval cancer diagnosis to RT, time developing motor deficits) and fractionation regimen were investigated. Factors significantly associated with post-RT ambulatory status on multivariate analysis were included in the score. The score for each factor was determined by dividing the post-RT ambulatory rate at 1 month (%) by 10. The total score represented the sum of these scores.

Results

In the multivariate analysis of the test group, age, primary tumor type, pre-RT ambulatory status, visceral metastases, and time developing motor deficits were significantly associated with post-RT ambulatory status. Total scores were 19 to 41 points. In the test group, post-RT ambulatory rates were 5% for 19-25 points, 35% for 26-30 points, 80% for 31-34 points, and 98% for 35-41 points (p < 0.001). 6-month survival rates were 11%, 21%, 59% and 76%, respectively. In the validation group, post-RT ambulatory rates were 4%, 33%, 77% and 98%, respectively (p < 0.001).

Conclusions

Patients achieving 19-25 points had very poor functional outcomes and survival, and may receive single-fraction RT for pain relief. Selected patients with 26-34 points may benefit from additional surgery. Patients achieving ≥35 points achieved favorable results after RT alone.

【 授权许可】

   
2014 Rades et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Patchell R, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ, Mohiuddin M, Young B: Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 2005, 366:643-648.
• [2]Rades D, Huttenlocher S, Bajrovic A, Karstens JH, Adamietz IA, Kazic N, Rudat V, Schild SE: Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors. Int J Radiat Oncol Biol Phys 2011, 81:e861-e868.
• [3]Rades D, Huttenlocher S, Dunst J, Bajrovic A, Karstens JH, Rudat V, Schild SE: Matched pair analysis comparing surgery followed by radiotherapy and radiotherapy alone for metastatic spinal cord compression. J Clin Oncol 2010, 28:3597-3604.
• [4]Rades D, Huttenlocher S, Evers JN, Bajrovic A, Karstens JH, Rudat V, Schild SE: Do elderly patients benefit from surgery in addition to radiotherapy for treatment of metastatic spinal cord compression? Strahlenther Onkol 2012, 188:424-430.
• [5]Homepage of the World Health Organization (WHO)http://www.who.int/healthinfo/survey/ageingdefnolder/en webcite
• [6]Orimo H, Ito H, Suzuki T, Araki A, Hosoi T, Sawabe M: Reviewing the definition of “elderly”. Geriatr Gerontol Int 2006, 6:149-158.
• [7]Rades D, Stalpers LJ, Veninga T, Schulte R, Hoskin PJ, Obralic N, Bajrovic A, Rudat V, Schwarz R, Hulshof MC, Poortmans P, Schild SE: Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol 2005, 23:3366-3375.
• [8]Maranzano E, Trippa F, Casale M, Costantini S, Lupattelli M, Bellavita R, Marafioti L, Pergolizzi S, Santacaterina A, Mignogna M, Silvano G, Fusco V: 8Gy single-dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiother Oncol 2009, 93:174-179.
• [9]Maranzano E, Bellavita R, Rossi R, De Angelis V, Frattegiani A, Bagnoli R, Mignogna M, Beneventi S, Lupattelli M, Ponticelli P, Biti GP, Latini P: Short-course versus split-course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. J Clin Oncol 2005, 23:3358-3365.
• [10]Douglas S, Huttenlocher S, Bajrovic A, Rudat V, Schild SE, Rades D: Prognostic factors for different outcomes in patients with metastatic spinal cord compression from cancer of unknown primary. BMC Cancer 2012, 12:261.
• [11]Douglas S, Schild SE, Rades D: A new score predicting the survival of patients with spinal cord compression from myeloma. BMC Cancer 2012, 12:425.
• [12]Yancik R, Ries LA: Aging and cancer in America: demographic and epidemiologic perspectives. Hematol Oncol Clin North Am 2000, 14:17-23.
• [13]Rades D, Lange M, Veninga T, Stalpers LJ, Bajrovic A, Adamietz IA, Rudat V, Schild SE: Final results of a prospective study comparing the local control of short-course and long-course radiotherapy for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys 2011, 79:524-530.
• [14]Rades D, Lange M, Veninga T, Rudat V, Bajrovic A, Stalpers LJ, Dunst J, Schild SE: Preliminary results of spinal cord compression recurrence evaluation (score-1) study comparing short-course versus long-course radiotherapy for local control of malignant epidural spinal cord compression. Int J Radiat Oncol Biol Phys 2009, 73:228-234.
• [15]Rades D, Fehlauer F, Stalpers LJ, Wildfang I, Zschenker O, Schild SE, Schmoll HJ, Karstens JH, Alberti W: A prospective evaluation of two radiotherapy schedules with 10 versus 20 fractions for the treatment of metastatic spinal cord compression: final results of a multicenter study. Cancer 2004, 101:2687-2692.
• [16]Rades D, Rudat V, Veninga T, Stalpers LJ, Basic H, Karstens JH, Hoskin PJ, Schild SE: A score predicting posttreatment ambulatory status in patients irradiated for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys 2008, 72:905-908.